Quick Answer
GT Biopharma, Inc. reported Total Revenue of $0.00 for fiscal year 2020.
GT Biopharma, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2020 | $0.00 | — |
| 2019 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | -100.0% |
| 2015 | $27.0K | -55.7% |
| 2014 | $61.0K | -83.4% |
| 2013 | $368.0K | +7.6% |
| 2012 | $342.0K | +1215.4% |
| 2011 | $26.0K | +136.4% |
| 2010 | $11.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $0.00 | — | — |
| June 30, 2021 | $0.00 | — | — |
| March 31, 2021 | $0.00 | — | — |
| September 30, 2020 | $0.00 | — | — |
| June 30, 2020 | $0.00 | — | — |
| March 31, 2020 | $0.00 | — | — |
| March 31, 2019 | $0.00 | — | — |
| June 30, 2018 | $0.00 | — | — |
- Over the 2010–2020 period, GT Biopharma, Inc.’s total revenue has declined by 100.0% (from $11.0 thousand to $0.00).
- The most recent figure is from GT Biopharma, Inc.’s fiscal year 2020 report (Form 10-K), filed with the SEC on April 16, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: